It often improves with: Balanced meals Protein-first eating Reducing simple carbohydrates More consistent meal timing True hypoglycemia should always be confirmed with testing rather than assumed
Uncommon: Constipation, skin reactions, arthralgia, hypoglycaemia, peripheral oedema
Lastly, semaglutide GLP-1 has been shown to help to reduce body weight and blood pressure, which is important for those with type 2 diabetes are may be overweight or obese
In skincare, they are studied for their ability to
The most frequent gastrointestinal side effects include: Nausea and vomiting : Very common, typically most pronounced during dose escalation Diarrhoea : Common to very common, though usually mild to moderate Constipation : Can occur due to delayed gastric emptying and reduced gut motility Abdominal pain and discomfort : Common Dyspepsia and gastro-oesophageal reflux : May worsen in susceptible individuals Other important adverse effects include: Gallbladder disorders : Cholelithiasis and cholecystitis have been reported, particularly with weight loss Dehydration and acute kidney injury : May occur secondary to severe gastrointestinal symptoms Hypoglycaemia : Risk increases when used with insulin or sulfonylureas, which may require dose adjustment Current limited evidence does not suggest an increased risk of inflammatory bowel disease (IBD) flares with GLP-1 agonists, though more data are needed
